Tambayar caca da kuma sayarwa mai karfi: Shin suna fada ne a cikin bambance-bambance masu ban tsoro? (2010)

Tattaunawar Clin Neurosci. 2010;12(2):175-85.

Donald W. Black , MD *

Donald W. Black, Sashen Harkokin Siyasa, Jami'ar Iowa Roy J. da Lucille A. Carver College of Medicine, Iowa City, Iowa, Amurka;

Martha Shaw , BA

Martha Shaw, Ma'aikatar Harkokin Siyasa, Jami'ar Iowa Roy J. da Lucille A. Carver College of Medicine, Iowa City, Iowa, Amurka;

Nancee Blum , MSW

Ka tafi zuwa ga:

Abstract

Dukkanin sayen siya (CB) da caca-caca (PG) an gabatar da shi a matsayin mambobi ne na rashin lafiya da ke fama da rashin lafiyar jiki (OCD). Harshen jigon ya samo asali ne a farkon 1990s kuma ya sami goyon baya mai girma, duk da rashin shaidar shaida. Samun sha'awa a cikin wannan zancen ya zama mahimmanci saboda wasu masu binciken sun bada shawara akan ƙirƙirar wani sabon nau'i wanda ya hada da wannan cuta a cikin DSM-5, yanzu a karkashin ci gaba. A cikin wannan labarin, marubuta sun bayyana asalin maɗaukaki-mai karfi (OC) da mahimman bayanansa, duba duka CB da PG, kuma suyi bayani game da bayanan da ke goyon baya da kuma a kan hanyar OC. Dukkanin lalacewar an kwatanta su dangane da tarihin su, fassarar, rarrabuwa, ilimin halitta, tarihin iyali, pathophysiology, da kuma kula da asibiti. Mawallafa sun ƙaddara cewa: (i) CB da PG bazai danganta da OCD ba, kuma akwai rashin shaidar da za a sanya su a cikin hanyar OC a DSM-V; (ii) PG ya kamata ya kasance tare da ciwon magungunan motsa jiki (ICDs); da kuma (iii) sabon samfurin asibiti na CB ya kamata a ƙirƙira kuma a ƙaddara shi a matsayin ICD.

keywords: samfurin tarawa, caca-bambance-bambance, bambance-bambance-bambance-rikice, rikice-rikicen motsi, fasin hali

A farkon shekarun 1990, sha'awa ta fara girma a kusa da manufar wani nau'in cutar obsessive-compulsive (OC). Hollander da wasu 1-3 sun rubuta game da nau'ikan cututtuka da suka shafi obsessive-compulsive disorder (OCD). Dangane da gogewarsa a matsayin mai bincike na OCD, Hollander ya ɗauki OCD a matsayin cibiyar bakan, kuma ya bayyana faɗinsa da kuma haɗuwa da sauran cututtukan tabin hankali da yawa. An yi la'akari da waɗannan cututtuka a matsayin suna kwance tare da axis na orthogonal na impulsivity vs compulsiveness, rashin tabbas vs tabbatacce, da fahimi vs motoric (fasali). Sauran masu bincike sun rungumi ra'ayin bakan OC cikin sauri saboda ya ba da sabuwar hanya don tunani game da alaƙar da ke tsakanin cututtuka da yawa da aka yi watsi da su, kuma yana iya bayar da sabbin zaɓuɓɓukan magani. 4 , 5 Ba duk masu bincike sun yarda ba, kuma an bayyana sake dubawa da yawa masu suka . 6-9

Duk da sukar da aka yi, manufar cewa ƙungiyar cututtuka tana da alaƙa da OCD har yanzu tana da babban sha'awa a ka'ida. Ra'ayin cewa cututtuka suna da alaƙa da OCD yana da mahimmanci ga tsarin rarrabuwa, kuma me yasa bai kamata ƙungiyar cututtuka ba ta da alaƙa da OCD? Wannan tambayar yanzu tana da sha'awa ɗaya domin waɗanda ke da alhakin ƙirƙirar bugu na biyar na Littafin Bincike da Ƙididdiga na Cututtukan Hankali (DSM-5) dole ne su yanke shawara ko za su ƙirƙiri wani rukuni daban don OCD da cututtukan da ke da alaƙa da su, ko kuma su ci gaba da OCD tare da cututtukan damuwa. Idan suka ƙirƙiri sabon rukuni don bakan OC, za su buƙaci su tantance faɗinsa.

Iyakokin OC sun faɗaɗa ko sun yi ƙasa bisa ga ra'ayin mai binciken da abin ya shafa. An bayyana shi a matsayin wanda ya haɗa da rikice-rikicen sarrafa motsin rai kamar caca ta hanyar cuta (PG), trichotillomania, da kleptomania; Tourette's da sauran rikice-rikicen tic; rikice-rikicen halayen da ba su dace ba (misali, matsalar halayyar kan iyaka); hypochondriasis da rashin lafiyar jiki; matsalolin cin abinci; da kuma cututtuka da dama da ba a san su a halin yanzu a cikin DSM-IV-TR 10 ba kamar siyan tilas (CB) da jarabar jima'i. 1 - 4 Masu bincike kaɗan ne suka bayar da shaida don tabbatar da alaƙa tsakanin cututtukan. Yawanci, irin waɗannan shaidun na iya haɗawa da kwatanta yanayin halitta, tarihin halitta, tarihin iyali, alamomin halittu, da amsawar magani. 11

OCD tana da matsayi mai mahimmanci a tsakiyar bakan. A halin yanzu an rarraba ta a cikin DSM-IV-TR 10 a matsayin matsalar damuwa, OCD ba ta da alaƙa da sauran matsalolin damuwa a cikin tsarin Rarraba Cututtuka na Duniya (ICD), 12 kuma Zohar et al 13 sun gabatar da wata hujja mai ƙarfi don rabuwa da waɗannan matsalolin. Da farko, OCD sau da yawa yana farawa ne tun yana yara, yayin da sauran matsalolin damuwa galibi suna da shekaru na farko na farawa. OCD yana da kusan rarraba jinsi daidai, ba kamar sauran matsalolin damuwa ba, waɗanda suka fi yawa a cikin mata. Nazarin cututtukan tabin hankali ya nuna cewa, ba kamar sauran cututtukan damuwa ba, mutanen da ke da OCD gabaɗaya ba sa samun ƙaruwar yawan amfani da miyagun ƙwayoyi. Nazarin iyali bai nuna wata alaƙa bayyananniyar alaƙa tsakanin OCD da sauran cututtukan damuwa ba. Tsarin kwakwalwa wanda ke shiga tsakani OCD ya bambanta da wanda ke cikin wasu cututtukan damuwa. A ƙarshe, OCD ta musamman ce dangane da martanin da take bayarwa ga masu hana serotonin reuptake inhibitors (SSRIs), yayin da magungunan noradrenergic, waɗanda ke da tasiri a cikin matsalolin yanayi, kuma suna da tasiri a cikin matsalolin damuwa, ba su da tasiri sosai a cikin OCD. A gefe guda kuma, benzodiazepines, waɗanda ba su da wani tasiri sosai ga OCD, galibi suna da tasiri ga sauran cututtukan damuwa. Bugu da ƙari, Zohar et al 13 sun yi jayayya cewa gane bakan zai taimaka wajen inganta rarrabuwa, don haka yana ba da damar yin cikakken bayani game da alamun endophenotype da na halitta waɗanda ke siffanta waɗannan yanayi, kuma cewa mafi kyawun rarrabuwa na iya haifar da ƙarin takamaiman jiyya.

Wani ɓangare na yiwuwar OC spectrum, babu wata hanyar da ta dace don rarraba cututtuka masu saurin motsawa da na tilastawa. Duk da cewa wasu sun yi Allah wadai da "magani" na halayen da ke da matsala kamar CB, tattaunawa ta 14 ta fi mayar da hankali kan yadda ya kamata a rarraba waɗannan cututtuka, alaƙarsu da wasu cututtukan OC spectrum, da kuma ko wasu daga cikinsu suna tsayawa su kaɗai a matsayin cututtuka masu zaman kansu (misali, CB, halayen jima'i na tilastawa).

Tsarin rarrabuwa daban-daban sun jaddada alaƙar da ke tsakanin rashin lafiyar OC da baƙin ciki ko wasu matsalolin yanayi, da cututtukan da ke shafar motsin rai (ICDs), ko kuma da matsalolin jaraba. Kwanan nan, an ba da shawarar cewa aƙalla wasu daga cikin matsalolin da aka haɗa a cikin tsarin OC za a sanya su cikin sabon nau'in bincike wanda ya haɗa da jarabar ɗabi'a da abubuwan maye. 15 "Sha'awar ɗabi'a" sun haɗa da cututtuka waɗanda Cibiyar Ƙasa kan Cin Zarafin Miyagun Kwayoyi (NIDA) ta ɗauka a matsayin samfuran jaraba na gaske saboda ba su gurɓata ta hanyar kasancewar wani abu na waje ba.

Tare da wannan batu a hankali, wannan labarin zai mayar da hankali akan matsayin PG da CB. Shin wadannan ɓangarorin sune wani ɓangare na OC irin yadda Yarjejeniyar Holland da abokan aiki suka bayyana? An fi la'akari da su yadda ya kamata a yi la'akari da rikici na jini (ICDs) ko ƙari? Shin suna da alaka da juna? Za a yi la'akari da waɗannan tambayoyi da sauran tambayoyin yayin da muke nazarin CB, PG, da kuma OC.

Samun karfi

An bayyana CB a cikin jerin sunayen masu tabin hankali na tsawon kusan shekaru 100. Likitan hauka na Jamus Emil Kraepelin mai shekaru 16 ya rubuta game da halin siyayya da kashe kuɗi da ba a sarrafa ba da ake kira oniomania ("sayen mania"). Daga baya likitan hauka na Switzerland Eugen Bleuler 17 ya ambato shi a cikin littafinsa na Lehrbuch der Psychiatrie:

A matsayin rukuni na ƙarshe, Kraepelin ya ambaci masu saye (oniomaniacs) waɗanda ko da siye yana da mahimmanci kuma yana haifar da raguwar basussuka marasa ma'ana tare da ci gaba da jinkirta biyan kuɗi har sai wani bala'i ya share yanayin kaɗan - kaɗan ba gaba ɗaya ba saboda ba sa taɓa yarda da duk basussukansu. …. Abin da ya fi muhimmanci shi ne rashin hanzari; ba za su iya taimakawa ba, wanda wani lokacin ma yana bayyana kansa a gaskiyar cewa ba tare da juriya ga ingantaccen ilimi ba, marasa lafiya ba za su iya tunani daban ba kuma su fahimci sakamakon abin da suka aikata, da kuma yiwuwar rashin yin sa.” (shafi na 540).

Kraepelin da Bleuler kowannensu ya ɗauki "sayen mania" a matsayin misali na wani abu mai amsawa ko hauka mai saurin motsawa, kuma ya sanya shi tare da kleptomania da pyromania. Wataƙila ra'ayin likitan hauka na Faransa Jean Esquirol na baya - bayan nan game da monomania ya rinjayi su, kalmar da ya yi amfani da ita wajen kwatanta mutane na yau da kullun waɗanda ke da wani nau'in damuwa game da cututtuka.

CB ba ta jawo hankali sosai ba har zuwa ƙarshen shekarun 1980 da farkon shekarun 1990 lokacin da masu binciken halayen masu amfani suka nuna cewa cutar ta yaɗu a tsakanin shekarun 19-21 kuma nazarin bayanin ya bayyana a cikin littattafan tabin hankali. 22-25 McElroy et al 22 sun haɓaka ma'anar aiki wanda ya ƙunshi fannoni na fahimta da halayya na CB. Ma'anarsu tana buƙatar shaidar rauni daga tsananin damuwa, tsangwama a cikin aikin zamantakewa ko aiki, ko matsalolin kuɗi/shari'a. Bugu da ƙari, ba za a iya danganta cutar da rashin hankali ko hypomania ba. Wasu ma'anoni sun fito ne daga masu binciken halayen masu amfani ko masana ilimin halayyar zamantakewa. Faber da O'Guinn 26 sun bayyana cutar a matsayin "sauye-saye na yau da kullun na wani salon da aka yi amfani da shi wanda mai amfani ya ji ba zai iya dakatarwa ko daidaita halayensa ba sosai" (shafi na 738). Edwards, 27 wani mai halayyar masu amfani, ya ba da shawarar cewa siyan tilas "wani nau'i ne na siyayya da kashe kuɗi wanda mai amfani da ke fama da shi yana da sha'awar siyayya da kashe kuɗi mai yawa wanda ba za a iya sarrafawa ba, na yau da kullun da maimaitawa don siyayya da kashe kuɗi (wanda ke aiki) ... a matsayin hanyar rage mummunan ji na damuwa da damuwa." (shafi na 67). Dittmar 28 ta bayyana manyan siffofi guda uku: sha'awar da ba za a iya jurewa ba, rashin iko, da kuma ci gaba duk da mummunan sakamako. Wasu masu bincike kan halayyar masu amfani da kayayyaki suna ɗaukar CB a matsayin wani ɓangare na ɗabi'un masu amfani da kayayyaki marasa kyau, waɗanda suka haɗa da caca ta hanyar cuta, satar shaguna, da cin zarafin bashi). 29

Ba a haɗa CB a cikin DSM-IV-TR10 ko Ƙungiyar Lafiya ta Duniya ba Rarraba Cututtuka ta Duniya, Bugu na Goma. 12 Ana muhawara kan ko za a haɗa CB a cikin DSM-5 . 30 McElroy et al 23 sun ba da shawarar cewa halayen siyayya na tilastawa na iya zama da alaƙa da "yanayi, damuwa-ko rashin lafiyar motsa jiki." Lejoyeux et al 31 sun danganta shi da rashin lafiyar yanayi. Wasu suna ɗaukar CB a matsayin yana da alaƙa da rashin lafiyar amfani da miyagun ƙwayoyi. 32 , 33 Wasu suna ba da shawarar rarraba CB a matsayin rashin lafiyar sarrafa motsa jiki 34 ko rashin lafiyar yanayi. 35

Faber da O'Guinn 26 sun kiyasta yawan CB a tsakanin 1.8% da 8.1% na yawan jama'a, bisa ga sakamakon wani bincike da aka yi ta wasiƙa inda aka gudanar da Ma'aunin Siyan Ƙarfi (CBS) ga mutane 292 da aka zaɓa don kimanta yawan alƙaluma na yawan jama'ar Illinois. (Kimanin yawan jama'a da ƙarancin ya nuna ma'aunin maki daban-daban da aka saita ga CB.) Kwanan nan, Koran et al 36 sun yi amfani da CBS don gano masu siye masu tilastawa a cikin wani bincike na wayar tarho na manya 2513 na Amurka, kuma sun kiyasta yawan maki a 5.8% na waɗanda suka amsa. Grant et al 37 sun yi amfani da MIDI don tantance CBD kuma sun ba da rahoton yawan rayuwa na 9.3% tsakanin marasa lafiya 204 da aka shigar da su cikin kwakwalwa a jere.

CB yana farawa ne a ƙarshen matasa/farkon shekarun 20, wanda zai iya danganta da 'yantar da kansu daga dangin nukiliya, da kuma shekarun da mutane za su iya fara tantance bashi. 34 Bincike ya nuna cewa kashi 80% zuwa 94% na mutanen da ke da CBD mata ne. 38 Sabanin haka, Koran et al 36 sun ba da rahoton cewa yawan CBD a cikin binciken wayar tarho na bazuwar ya kusan daidai da na maza da mata (5.5% da 6.0%, bi da bi). Bincikensu ya nuna cewa bambancin jinsi da aka ruwaito na iya zama na wucin gadi, domin mata sun fi yarda da halayen siyayya marasa kyau fiye da maza cikin sauƙi. Maza sun fi bayyana siyayyar tilastawa a matsayin "tattarawa."

Bayanai daga nazarin asibiti sun tabbatar da yawan kamuwa da cututtukan tabin hankali, musamman ga yanayi (21% zuwa 100%), damuwa (41% zuwa 80%), amfani da miyagun ƙwayoyi (21% zuwa 46%), da kuma matsalolin cin abinci (8% zuwa 35%). 38 Matsalolin sarrafa motsin rai suma sun zama ruwan dare (21% zuwa 40%). Schlosser et al 25 sun tantance yawan kamuwa da cututtukan Axis II a cikin mutanen da ke fama da CB ta amfani da kayan aikin rahoto kai tsaye da kuma wata hira mai tsari. Kusan kashi 60% na mutane 46 sun cika sharuddan akalla matsalar halayyar mutum ɗaya ta hanyar yarjejeniya tsakanin kayan aikin biyu. Cututtukan halayyar da aka fi gano su sune nau'ikan obsessive-compulsive (22%), avoidant (15%), da kuma iyaka (15%).

Wani hoto na musamman da aka yi amfani da shi a asibiti na mai siye mai tilastawa ya bayyana. Black 39 ya bayyana matakai huɗu ciki har da: (i) tsammani; (ii) shiri; (iii) siyayya; da (iv) kashe kuɗi. A mataki na farko, mutumin da ke da CB ya shagaltu da samun wani abu na musamman, ko kuma yin siyayya. Wannan sai kuma lokacin shiri wanda ake yin tsare-tsare. Wannan mataki sai kuma ainihin abin da ya faru a siyayya, wanda mutane da yawa da ke da CB ke bayyana a matsayin abin sha'awa sosai. 25 Ana kammala aikin da siyayya, sau da yawa sai kuma jin kunya ko takaici. 36

Wataƙila alamar CB ita ce shagaltuwa da siyayya da kashe kuɗi. Wannan yawanci yana sa mutum ya ɓatar da sa'o'i da yawa a kowane mako yana yin waɗannan halaye. 24 , 25 Mutanen da ke da CB sau da yawa suna bayyana ƙaruwar tashin hankali ko damuwa wanda ke raguwa lokacin da aka yi sayayya. Halayen CB suna faruwa duk shekara, amma suna iya zama mafi matsala a lokacin Kirsimeti da sauran bukukuwa, da kuma a lokacin ranar haihuwar 'yan uwa da abokai. Masu siyan da ba su dace ba galibi suna sha'awar kayan masarufi kamar tufafi, takalma, sana'o'i, kayan ado, kyaututtuka, kayan shafa, da ƙananan faifan diski (ko DVDs) 24 , 25 CB ba shi da alaƙa da hankali ko matakin ilimi, kuma an rubuta shi a cikin mutanen da ke da nakasa ta hankali. 40 Hakazalika, samun kuɗi ba shi da alaƙa da CB, saboda mutanen da ke da ƙarancin kuɗi na iya shagaltuwa da siyayya da kashe kuɗi kamar mutanen da suka fi arziki. 38 , 40

Nataraajan da Goff 42 sun gano abubuwa biyu masu zaman kansu a cikin CB: (i) sha'awar siyayya ko sha'awa, da (ii) matakin iko akan siyayya. A cikin samfurin su, masu siyayya masu tilastawa suna haɗa sha'awar girma da ƙarancin iko. Wannan ra'ayi ya yi daidai da rahotannin asibiti cewa masu siyayya masu tilastawa suna shagaltuwa da siyayya da kashe kuɗi kuma za su yi ƙoƙarin tsayayya da sha'awarsu, sau da yawa ba tare da nasara ba. 24 , 38

Nazarin da aka yi a sassan jiki ya nuna cewa cutar tana da tsanani, kodayake tana canzawa a cikin tsanani da ƙarfi. 22 , 25 Aboujaoude et al 43 sun ba da rahoton cewa mutanen da suka amsa maganin citalopram za su iya ci gaba da samun sauƙi a lokacin bin diddigin shekara 1, suna nuna cewa magani na iya canza tarihin halitta na cutar. Lejoyeux et al 44 sun ba da rahoton cewa CB yana da alaƙa da yunƙurin kashe kansa, kodayake babu rahotannin cutar da ke haifar da kashe kansa gaba ɗaya.

Akwai wasu shaidu da ke nuna cewa CB tana gudana a cikin iyalai kuma a cikin waɗannan iyalai yanayi, damuwa, da cututtukan amfani da miyagun ƙwayoyi sun fi yawan jama'a. Black et al 45 sun yi amfani da hanyar tarihin iyali don tantance dangi 137 na farko na mutane 31 da ke ɗauke da CB. 'Yan uwa sun fi waɗanda ke cikin rukunin kwatantawa fuskantar damuwa, shan giya, matsalar amfani da miyagun ƙwayoyi, "kowace cuta ta tabin hankali" da "fiye da cutar tabin hankali ɗaya." An gano CB a kusan kashi 10% na dangin farko, amma ba a tantance shi a cikin rukunin kwatanta ba.

Ka'idojin jijiyoyi sun ta'allaka ne akan watsawar jijiyoyi masu rikitarwa, musamman waɗanda suka shafi tsarin serotonergic, dopaminergic, ko opioid. An yi amfani da masu hana sake ɗaukar serotonin (SSRIs) na zaɓi don magance CB, 46-50 a wani ɓangare saboda kamanceceniya tsakanin CB da OCD, wata cuta da aka sani da amsawa ga SSRIs. An yi hasashen cewa dopamine yana taka rawa a cikin "dogara ga lada," wanda aka yi iƙirarin yana haɓaka jarabar halaye, kamar CB da PG 15 Rahotannin shari'o'i da ke nuna fa'ida daga opioid antagonist naltrexone sun haifar da hasashe game da rawar da masu karɓar opioid ke takawa 51 Duk da haka, babu wata shaida kai tsaye da ke tallafawa rawar da waɗannan tsarin neurotransmitter ke takawa a cikin asalin CB.

Saboda CB yana faruwa ne galibi a ƙasashen da suka ci gaba, an gabatar da abubuwan al'adu da zamantakewa a matsayin waɗanda ke haifar da ko kuma ke haɓaka wannan cuta. 39 Abin sha'awa, Neuner et al 52 sun ba da rahoton cewa yawan CB a Jamus ya ƙaru bayan sake haɗuwa, yana nuna cewa abubuwan zamantakewa na iya taimakawa wajen ci gaban CB. Waɗannan na iya haɗawa da kasancewar tattalin arziki mai tushen kasuwa, samuwar kayayyaki, samun bashi cikin sauƙi, da kuma kuɗin shiga da za a iya zubar da shi. 14

Babu wani magani na yau da kullun, kuma an ba da shawarar duka ilimin halayyar ɗan adam da magunguna. Nazarce-nazarce da dama sun ba da rahoton maganin ilimin halayyar ɗan adam na CB. 53-55 Kwanan nan , an ƙirƙiri samfuran maganin fahimta-halayyar ɗan adam (CBT) don CB, da yawa daga cikinsu suna amfani da maganin rukuni 56 , 57 Mitchell et al 57 sun gano cewa ƙungiyar CBT ta samar da ci gaba mai mahimmanci idan aka kwatanta da jerin jira a cikin wani bincike na gwaji na makonni 12. An ci gaba da ingantawa da aka danganta da CBT a lokacin bin diddigin watanni 6. Benson 58 ta ƙirƙiro cikakken shirin taimakon kai wanda mutane da ƙungiyoyi za su iya amfani da shi.

Nazarin magani ta amfani da magungunan psychotropic sun samar da sakamako iri ɗaya. Rahotannin farko sun nuna fa'idar magungunan rage radadi wajen magance CB 22 , 23 Black et al 46 sun ba da rahoton sakamakon wani gwaji mai lakabin budewa inda mutanen da aka ba wa fluvoxamine suka nuna fa'ida. Gwaje-gwaje guda biyu da aka yi bazuwar da aka sarrafa bazuwar (RCTs) sun gano cewa maganin fluvoxamine bai fi placebo kyau ba. 47 , 48 Koran et al 51 daga baya sun ba da rahoton cewa mutanen da ke da CB sun inganta tare da citalopram mai lakabin budewa. A wani bincike na baya, mutanen da aka ba wa citalopram mai lakabin budewa; waɗanda aka yi la'akari da su a matsayin masu amsawa an bazuwar su zuwa citalopram ko placebo. An dawo da alamun siyayya na tilas a cikin mutane 5/8 (62.5%) da aka ba wa placebo idan aka kwatanta da 0/7 waɗanda suka ci gaba da shan citalopram. A cikin wani gwaji da aka tsara wanda aka tsara daidai, escitalopram bai rabu da placebo ba. 52 Saboda binciken maganin ya gauraye, babu shawarwarin magani da aka ba da tallafi sosai. Gwaje-gwajen Openlabel gabaɗaya sun samar da sakamako mai kyau, amma RCTs ba su yi ba. Fassarar waɗannan sakamakon binciken yana da sarkakiya saboda yawan amsawar placebo har zuwa kashi 64%.

Tambaya

Ana ƙara fahimtar PG a matsayin babbar matsalar lafiyar jama'a. An kiyasta cewa PG 59 zai kashe al'umma kimanin biliyan 5 a kowace shekara da kuma ƙarin kuɗaɗen rayuwa biliyan 40 don rage yawan aiki, ayyukan zamantakewa, da asarar masu ba da bashi. Wannan cuta tana da matuƙar illa ga ingancin rayuwa ban da alaƙarta da cututtukan tabin hankali masu alaƙa, nakasar zamantakewa, da kashe kai. 59 - 61 Matsalolin da suka shafi iyali sun haɗa da matsalar kuɗi, cin zarafin yara da mata, da saki da rabuwa. 61

Duk da cewa an san halayen caca masu matsala tsawon ƙarni, al'ummar masu tabin hankali galibi suna yin watsi da shi. Bleuler, mai shekaru 17 yana ambaton Kraepelin, mai shekaru 16 yana ɗaukar PG, ko "matsin caca," wata cuta ta musamman ta sha'awa . An fara lissafa sharuɗɗan PG a cikin 1980 a cikin DSM-III. 62 Daga baya an gyara sharuɗɗan, kuma a cikin DSM-IV-TR, an tsara 10 bayan waɗanda aka yi amfani da su don dogaro da abubuwa kuma suna jaddada fasalulluka na haƙuri da janyewa. An bayyana PG a matsayin "dabi'ar caca mai ɗorewa da maimaitawa (ma'auni A) wanda ke wargaza ayyukan mutum, iyali, ko sana'a..." An lissafa halaye goma na musamman na rashin daidaitawa, kuma ana buƙatar >5 don ganewar asali. Sharuɗɗan sun mayar da hankali kan rashin ikon sarrafa halayen caca; ci gaba da tabarbarewar cutar; da ci gaba duk da mummunan sakamako. Ana iya gano cutar ne kawai lokacin da aka kawar da mancin (Ma'auni B). A cikin yunƙurin daidaita hanyoyin sunaye da aunawa, Shaffer da Hall 63 sun haɓaka tsarin rarrabuwa na matakai da yawa wanda yanzu masu binciken caca suka yarda da shi sosai.

A halin yanzu ana rarraba PG a matsayin matsalar sarrafa sha'awa a cikin DSM-IV-TR. 10 A gefe guda, wasu masu bincike sun nuna cewa PG yana da alaƙa da OCD, 1 , 64 wasu kuma suna jayayya game da irin wannan dangantaka. 65 A gefe guda kuma, ana ɗaukar PG a matsayin cuta mai jaraba. 66 , 67 Kwanan nan an gabatar da shi a matsayin ɗan takara don haɗawa a cikin sabon rukuni na "jarabawar ɗabi'a." 15 Kwanan nan an gabatar da shi a matsayin ɗan takara don haɗawa a cikin sabon rukuni na "jarabawar ɗabi'a." 15 Kwanan nan an yi hasashen cewa yawan kamuwa da cutar ga PG ya tashi daga 1.2% zuwa 3.4% a cikin yawan jama'a. 68 , 69 Yawan kamuwa da cutar ya karu a yankunan da yawan kamuwa da cutar caca ya ƙaru. 70. 71 Wani bincike na ƙasa ya nuna cewa samuwar gidan caca a cikin mil 50 yana da alaƙa da kusan ƙaruwa sau biyu a yawan kamuwa da cutar PG. 59 Halin caca yawanci yana farawa ne a lokacin samartaka, tare da PG yana tasowa a ƙarshen shekarun 20 ko farkon shekarun 30, 72 kodayake yana iya farawa a kowane zamani har zuwa tsufa. Adadin PG ya fi yawa a cikin maza, amma gibin jinsi na iya raguwa. PG yana da farkon farawa daga baya a cikin mata amma yana ci gaba da sauri ("telescoping") fiye da maza, 73 a matakin kama da wanda aka lura a cikin matsalolin barasa. Al'ummar da ke cikin haɗari sun haɗa da manya masu fama da matsalar tabin hankali ko shan muggan kwayoyi, mutanen da aka tsare a gidan yari, 'yan Afirka-Amurka, da mutanen da ke da ƙarancin matsayin tattalin arziki. 74 , 75

Bincike bai tabbatar da nau'ikan PG ba, amma wataƙila bambancin da aka fi tattaunawa akai shine tsakanin "masu neman tserewa" da "masu neman jin daɗi." 76 Masu neman tserewa galibi tsofaffi ne waɗanda ke yin caca saboda gundura, daga baƙin ciki, ko don cike lokaci, kuma suna zaɓar nau'ikan caca marasa amfani kamar na'urorin caca. Masu neman jin daɗi galibi suna ƙanana ne, kuma sun fi son jin daɗin wasannin kati ko wasannin tebur waɗanda suka haɗa da shigar da aiki. 76 Blaszczynski da Nower 77 sun gabatar da samfurin "hanyoyi" wanda ya haɗa da halittu, ci gaba, fahimta, da sauran abubuwan da ke haifar da caca mara kyau. Sun gano ƙungiyoyi uku: a) masu caca masu yanayin ɗabi'a; b) masu caca masu rauni a cikin motsin rai; da kuma c) masu caca masu rashin son zamantakewa, masu saurin motsa jiki. Masu caca masu yanayin ɗabi'a ba su da takamaiman ilimin halayyar ɗan adam, amma suna yanke hukunci mara kyau game da caca. Masu caca masu rauni a cikin motsin rai suna fama da baƙin ciki ko damuwa kafin su kai ga mutuwa, kuma suna da tarihin rashin iya jurewa. A ƙarshe, masu caca masu rashin son zamantakewa, masu saurin motsa jiki suna da matukar damuwa kuma suna da fasalulluka na rashin lafiyar halayyar ɗan adam da rashin son rai waɗanda ke nuna rashin aikin jijiyoyi.

Rashin lafiyar tabin hankali shine ƙa'ida, ba banda ba, ga mutanen da ke da PG. Nazarin al'umma da na asibiti sun nuna cewa matsalolin shan ƙwayoyi, matsalolin yanayi, da matsalolin ɗabi'a suna da yawa a cikin mutanen da ke da PG. 78 A cikin samfuran asibiti, daga 25% zuwa 63% na masu caca da ke da alaƙa da cutar sankarau sun cika sharuɗɗan rayuwa don matsalar shan ƙwayoyi. 79 Haka kuma, daga 9% zuwa 16% na masu shan ƙwayoyi masu yiwuwa 'yan caca ne masu alaƙa da cutar sankarau. 79 PG kuma yana da alaƙa da ƙaruwar yawan rikice-rikicen yanayi, kuma gabaɗaya ana kiyasta cewa kashi 13% zuwa 78% na mutanen da ke da matsalar caca suna fuskantar matsalar tabin hankali. 79 A gefe guda kuma, ba a gano cewa marasa lafiya da ke da matsalar tabin hankali suna da ƙaruwar PG ba.

Ƙididdigar sauran nakasassun cuta (ICDs) ya fi girma a cikin mutane da ke da caca na ban dariya fiye da

yawan jama'a. Masu bincike sun bayar da rahoton cewa adadin ya kama daga 18% zuwa 43% ga ɗaya ko fiye da ICD. 79 CB ya bayyana a matsayin ICD mafi yawan kamuwa da cuta a cikin mutanen da ke da PG, wataƙila saboda duka cututtukan suna da halaye na mai da hankali, gamsuwar kuɗi, da musayar kuɗi. Mutanen da ke da ICD ɗaya sun fi fuskantar wata alama, wanda ke nuna cewa suna da babban karo a tsakaninsu.

Matsalolin ɗabi'a sun zama ruwan dare a tsakanin mutanen da ke fama da PG, musamman waɗanda ke cikin "ƙungiya ta B." An ware matsalar ɗabi'a ta rashin zamantakewa a matsayin tana da alaƙa ta kud da kud da PG, wataƙila saboda laifuka da caca suna faruwa akai-akai, tare da ƙimar da ta kama daga 15% zuwa 40%. 79 , 80 Akalla wani bincike da aka yi kan mutanen da ke fama da rashin ɗabi'a ta rashin zamantakewa ya nuna yawan PG. 81

Ana kyautata zaton PG a matsayin mai dorewa kuma mai ci gaba. 82 , 83 Wannan ra'ayi yana cikin DSM-IV-TR 10 wanda ke cewa muhimmin fasalin PG shine "dabi'ar caca mai dorewa da kuma maimaituwa ... wanda ke wargaza ayyukan mutum, iyali, ko sana'a" (shafi na 671). Waɗannan ra'ayoyin sun sami tasiri daga lura na farko na Custer 84 wanda ya bayyana PG a matsayin rashin lafiya mai ci gaba, mai matakai da yawa wanda ke farawa da matakin nasara, sannan kuma matakin rashin nasara, da kuma matakin yanke ƙauna. Mataki na ƙarshe, wanda ya daina, ya wakilci jin rashin bege. 85 Wasu sun yi iƙirarin cewa yawancin masu caca da ke fama da cutar tabin hankali suna fuskantar "babban nasara" a farkon ayyukansu na caca wanda ke haifar da su kai tsaye ga zama masu jaraba. Matakai huɗu na PG na Custer sun sami karɓuwa sosai duk da rashin bayanan gwaji.

Aikin da aka yi kwanan nan yana haifar da sake duba waɗannan ra'ayoyin. LaPlante et al 86 sun yi bitar bincike guda biyar 87-91 waɗanda suka cika sharuɗɗansu na bayar da rahoton bayanai na tsawon lokaci game da caca waɗanda ba su haɗa da samfurin magani ba . LaPlante et al sun ba da rahoton cewa, daga nazarin huɗu da suka haɗa da masu caca na matakin 3 (watau, mutanen da ke da PG), yawancin masu caca sun inganta, kuma sun koma ƙasa, kuma ƙimar inganta rarrabuwa ta kasance "aƙalla mafi girma fiye da 29%. Sakamakon ya yi kama da na masu caca na matakin 2 (watau, "masu haɗari"). Waɗanda suka kasance masu caca na matakin 0 zuwa 1 a farkon ba su da wuya su ci gaba zuwa matakin mafi girma (watau, mafi tsanani) na halayen caca, kuma ban da ɗaya, binciken ya nuna cewa 'yan caca na matakin 2 sun inganta ta hanyar komawa mataki na 1. La Plante et al 86 sun kammala da cewa waɗannan nazarin suna ƙalubalantar ra'ayin cewa PG ba shi da matsala, kuma suna ba da shawarar cewa masu caca da yawa suna inganta kai tsaye, kamar yadda mutane da yawa masu shan muggan kwayoyi suke yi. Binciken ya nuna cewa waɗanda ba sa caca ko yin caca ba tare da matsala ba galibi suna zama marasa matsala; Waɗanda ke da matsalar caca suna motsawa daga mataki ɗaya zuwa wani, kodayake alkiblar gabaɗaya ita ce inganta rarrabuwa.

Bayanan tarihin iyali sun nuna cewa PG, matsalolin yanayi, da matsalolin amfani da miyagun ƙwayoyi sun fi yawa a tsakanin dangin mutanen da ke da PG fiye da na sauran jama'a. 92 , 93 Nazarin tagwaye kuma sun nuna cewa caca tana da wani abu da aka gada. 94 Nazarin aikin neuroimaging ya nuna cewa tsakanin mutanen da ke da PG, alamun caca suna haifar da sha'awar caca da kuma yanayin aiki na ɗan lokaci na canje-canje a cikin tsarin kwakwalwa na gaba, paralimbic, da limbic, wanda ke nuna cewa caca na iya wakiltar aikin frontolimbic mara aiki 95

Babu wata yarjejeniya game da yadda ya kamata a yi wa PG magani. Mutane kalilan ne ke da PG da ke neman magani, 96 kuma har zuwa kwanan nan babban abin da ake yi wa maganin ya zama shiga cikin Gamblers Anonymous (GA), wani shiri mai matakai 12 wanda aka tsara bisa ga Alcoholics Anonymous. Halartar GA kyauta ne kuma ana samun surori a ko'ina cikin Amurka, amma bin diddigin lamarin ba shi da kyau kuma nasarar ta yi muni. An ƙirƙiri shirye-shiryen jiyya da gyaran marasa lafiya da suka yi kama da na waɗanda ke da cututtukan shan ƙwayoyi, kuma suna da amfani ga wasu 98 , 99 Duk da haka, waɗannan shirye-shiryen ba su samuwa ga yawancin mutanen da ke da PG saboda yanayin ƙasa ko rashin samun dama (misali, inshora/albarkatun kuɗi). Kwanan nan, CBT da yin tambayoyi masu ƙarfafa gwiwa sun zama hanyoyin magani da aka kafa. Shirye-shiryen keɓe kai 100 sun sami karɓuwa kuma sun yi kama da suna amfanar da zaɓaɓɓun marasa lafiya. 101 Duk da cewa dokoki sun bambanta, gabaɗaya sun haɗa da keɓe kai da son rai daga gidajen caca na ɗan lokaci a cikin haɗarin kama su saboda shiga ba bisa ƙa'ida ba. Nazarin maganin magunguna ya sami ci gaba, amma sakamakonsu bai daidaita ba. A takaice, magungunan opioid masu adawa da naltrexone da nalmefene sun fi placebo kyau a gwaje-gwajen da aka sarrafa bazuwar (RCTs) 102 , 103 amma gwaje-gwajen da aka sarrafa na paroxetine da bupropion ba su da kyau. 104 , 105 Nazarin da aka yi a fili na nefazodone, citalopram, carbamazepine, da escitalopram sun kasance masu ƙarfafa gwiwa, amma ana buƙatar a bi su tare da nazarin da aka yi amfani da shi yadda ya kamata kuma aka sarrafa. 106-109

Amfani mai mahimmanci tsakanin CB / PG da OCD

Abinda ke tsakanin CB / PG da OCD ya kasance bai tabbata ba. Cikin hada da CB da PG a cikin wani bidiyon OC, yayin da suke da hankali, suna dogara ne akan ra'ayi kuma ba hujjoji ba. Yaya aka yi ta gwagwarmaya irin wannan cuta ta kusan shekaru 100. Sanarwar ta fi yawan jin dadin kasancewar su a cikin rikici na rikici. Don dalilai na tarihi, kuma saboda rashin fahimtar bayanai, mun yarda cewa cutar ta biyu dole ne ta kasance tare da ICD har sai an gabatar da shaidar tabbatarwa don taimakawa ko dai tare da rikici ko kuma OC.

Alaƙa mafi bayyananniyar alaƙa tsakanin CB da PG da OCD ita ce ta musamman. Kowace cuta ta ƙunshi halaye masu maimaitawa waɗanda galibi ke faruwa a martanin tunani da sha'awa masu yawa; shiga cikin wannan hali - aƙalla na ɗan lokaci - zai gamsar da sha'awar, da/ko rage tashin hankali da damuwa da suka gabaci wannan hali. Duk da haka, babban bambanci tsakanin CB/PG da OCD shine cewa halayen (siyayya, caca) ana ɗaukar su a matsayin masu son kai; wato, ana ɗaukar su a matsayin masu daɗi da kyawawa, yayin da halayen da ke da alaƙa da OCD ba sa taɓa zama ba, kuma kusan duk marasa lafiya suna son a kawar da su. Ba haka yake da siyayya da caca ba: mutumin da ke da CB ko PG yana ganin halayen suna da daɗi sosai, kuma yana son dakatar da halayen ne kawai lokacin da sakamakonsu na biyu mai illa ya zama mai yawa. Masu goyon bayan OC bakan suna nuna haɗuwa tsakanin waɗannan cututtuka da OCD. Nazarin cututtukan da ke tattare da su ya gano cewa a cikin samfuran asibiti daga 3% zuwa 35% na mutanen da ke da CB suna da OCD mai kama da juna. 22 , 46 A gaskiya ma, kasancewar CB na iya siffanta wani takamaiman rukuni na marasa lafiya na OCD, 110 , 111 musamman waɗanda ke tarawa. Tara dukiya wata alama ce ta musamman da ta ƙunshi mallakar kadarorin da ba su da amfani ko ƙima ko kuma ba a zubar da su ba. 112 Duk da haka, ba kamar abubuwan da mai tarawa na yau da kullun ke riƙewa ba, abubuwan da mutumin da ke da CB ya saya ba su da amfani ko kuma ba su da amfani.

CB sau da yawa yana kama da wanda ke da alaƙa da ICDs. Black da Moyer 80 da Grant da Kim 72 kowannensu ya ba da rahoton ƙaruwar CB a tsakanin samfuran 'yan caca masu cutar kansa (23% da 8%, bi da bi). Haka kuma, sauran rikice-rikicen sarrafa motsin rai sun zama ruwan dare a tsakanin masu siyayya masu tilastawa. Nazarin 39 na cututtukan da ke tattare da PG sun fi gauraye, kodayake galibi suna ba da rahoton mafi girma na OCD fiye da na jama'a gabaɗaya. Juyawar ba ta yi kama da gaskiya ba. Kwatancen Axis II ya nuna cewa manyan rikice-rikicen da ke da alaƙa da OCD sune rikice-rikicen "cluster C". Duk da cewa babu wasu rikice-rikicen axis II da ke da alaƙa da PG ko CB, rikice-rikicen "cluster B" sun bayyana suna da yawa, musamman rashin lafiyar halayyar zamantakewa.

Binciken kai tsaye kan halayen OC na mutanen da ke da PG ya gano cewa waɗanda ke da PG sun sami maki mafi girma fiye da waɗanda ba su da ma'aunin auna halayen OC. 64 CB da PG suma suna da babban sha'awar halaye. 19 , 113

Wasu shaidu na iya fitowa daga nazarin iyali game da CB, PG, ko OCD. Akwai ƙananan nazarin iyali game da waɗannan cututtuka, kuma babu wanda ya goyi bayan dangantaka ta iyali tsakanin waɗannan cututtuka. A cikin binciken tarihin iyali guda ɗaya da aka gudanar na CB, Black et al 45 ba su sami alaƙa da OCD ba. A cikin nazarin iyali guda biyu, ɗaya yana amfani da hanyar tarihin iyali, ɗayan kuma yana amfani da hanyar hirar iyali, masu binciken ba su iya kafa alaƙa tsakanin PG da OCD ba. 114 , 115

Duba wannan haɗin gwiwa ta hanyar nazarin iyali na OCD shi ma ya kasa samun alaƙa. Ba Black et al 114 ko Bienvenu et al 115 ba su sami damar kafa dangantaka ta iyali tsakanin OCD da PG ba.

Hakanan ana amfani da alamomi na zamantakewar mutum don nuna cewa za'a iya danganta cuta, misali gaskiyar cewa duka maye gurbi da rikitarwa na mutunci suna yawan samuwa a cikin maza. Amma duk da haka, babu wani bambanci a rarraba mata cikin waɗannan matsaloli. Tare da PG akwai bayyananne ga namiji; tare da Babban Bankin na CB; tare da OCD, rarraba jinsi a rarraba daidai.

Idan wadannan halayen suna da alaƙa, tarihin su da kuma hanya zasu kasance daidai. CB da OCD sun bayyana suna da farawa a cikin matasan marigayi ko kuma farkon 20s. PG ya bayyana yana da ɗan gajeren lokaci daga baya, tare da mata masu tasowa yawancin cutar fiye da maza, amma suna bin hanyar briefer daga farkon caca don ci gaba da rashin lafiya. Wannan shi ne abin da ake gani da barasa, amma ba OCD ba. Tare da CB, PG, da kuma OCD suna dauke da yawanci na yau da kullum, amma irin wannan ya tsaya a can. Ga CB da PG, yayin da ba a kula da hankali ba, nazarin na tsawon lokaci, bayanai sun nuna cewa cututtuka na iya zama episodic, watau, zai iya ba da dama ga tsawon lokuta dangane da ɗayan abubuwan da ke waje kamar su tsoron sakamakon, misali, bankruptcy ko saki, ko rashin samun kudin shiga; OCD yana da sauki remits. Dangane da hadarin da ake yi na kashe kansa, an bayar da rahoton PG na kawo hadari ga gwagwarmayar kashe kansa da kuma aiwatar da kisan kai; tare da Babban Bankin CB, akwai rahotanni game da yunkurin kashe kansa, amma ba a kammala su ba; tare da OCD, bayanai suna da yawa, amma kuma, haɗarin kammala kashe kansa yana dauke da ƙananan.

A nan kuma, lokacin da aka yarda da maganin magani, an san OCD ne da kyau don amsawa sosai ga magungunan antidressing inhibitors na serotonin, da kuma farfadowa da halayyar halayyar halayyar zuciya. CB da PG ba su da cikakken bayani game da maganin magani, kuma mafi yawan maganganun magani sun nuna cewa PG zai iya amsawa ga masu tsaikowa na opioid. An bayar da rahoton CB da PG don amsawa ga CBT, amma cikar da ingancin amsawa ba kamar wanda aka gani ba tare da OCD.

Kasancewar alamun halittu iri ɗaya wata hanya ce ta tantance alaƙar da ke tsakanin waɗannan cututtuka. Wannan aikin yana da cikas saboda gaskiyar cewa babu ɗayan waɗannan cututtuka da ke da alamun da aka dogara da su. Duk da haka, wani bincike na aikin maganadisu mai amsawa (fMRI) na PG ya nuna cewa matsalar tana nuna yanayin kunnawa mara kyau a cikin takamaiman yankuna na gaba-gaba bayan fallasa alamun. Potenza et al 86 sun fassara waɗannan binciken a matsayin shaida don kamanceceniya tsakanin hanyoyin kwakwalwa a cikin PG da jarabar miyagun ƙwayoyi, yayin da aka gano akasin alkiblar kunna kwakwalwa mafi girma a cikin OCD. Hakazalika, Goodriaan et al 116 sun sake duba binciken kan bayanan kwayoyin halitta na neurochemical da kwayoyin halitta da suka shafi PG. Sun kammala da cewa akwai shaidar rikicewar watsawar jijiyoyi da suka shafi dopamine (DA), serotonin, da norepinephrine; kuma "... sun yi daidai da binciken kunna kwakwalwa mara kyau a cikin hanyoyin lada, inda DA muhimmin mai watsawa ne" (shafi na 134). An lura cewa dopamine yana taka muhimmiyar rawa wajen sha'awar da janyewa a cikin matsalolin amfani da sinadarai. Duk da cewa ba a fayyace cikakken bayani game da watsawar jijiyoyi da ke cikin OCD ba, tsarin serotonin na tsakiya shine mafi yawan bincike. Wannan wataƙila saboda ƙarfin tasirin SSRIs wajen magance OCD.

Gabaɗaya, nazarin ilimin halayyar ɗan adam na PG ya nuna cewa 'yan caca masu cutar pathological sun raunana aiki a fannoni da dama na aikin zartarwa, ciki har da kulawa, rage jinkiri, da yanke shawara. 115 - 117 Tare da OCD, binciken ilimin halayyar ɗan adam bai daidaita ba; akwai shaidar rashin amsawa da hana amsawa da kuma canjin hankali, amma ƙaramin shaida ne na rashin koyo da yanke shawara. 118 A fahimtarmu, babu wani nazarin ilimin halayyar ɗan adam na mutanen da ke da CB.

Tsarin mahimmancin tsari

Idan CB da PG ba su da wani ɓangare na bidiyon OC, a ina ya kamata a rarraba su? Saboda babu kusan wata hujja da ke nuna dangantakar da ke tattare da yanayin yanayi, yiwuwar yiwuwar kawar da wannan yiwuwar. Daga sauran tsare-tsaren, 'yan takara mafi mahimmanci sun hada da PG da CB tare da ICDs, ko kuma su motsa su zuwa wani nau'in da ke tattare da cuta mai amfani.

Ci gaba da PG da CB tare da ICDs shine zaɓi mafi sauƙi: An riga an rarraba PG a matsayin ICD, kuma yayin da CB ba a haɗa shi a halin yanzu a cikin DSM-IV-TR ba, a tarihi an ɗauke shi a matsayin cuta mai saurin motsawa. Dukansu PG da CB suna da siffofi iri ɗaya na asibiti waɗanda suka haɗa da kasancewar sha'awar son kai da ke haifar da amsawar ɗabi'a. Amsar (misali, caca, siyayya) tana gamsar da sha'awar da/ko kuma tana rage tashin hankali ko damuwa na ɗan lokaci, amma sau da yawa ana bin ta da jin laifi ko kunya, kuma a ƙarshe yana haifar da sakamako mara kyau, na biyu. Halayen suna da tsayi ko na ɗan lokaci, kuma suna iya yin watsi da kansu, wani lokacin a martani ga yanayi na waje. Shekarun farko da rarraba jinsi sun bambanta, kamar yadda aka tattauna a baya. Wataƙila, ana iya ɗaukar CB a matsayin daidai da mace kamar PG, saboda suna da bambancin rarraba jinsi: maza sun fi rinjaye tsakanin waɗanda ke da PG; mata sun fi rinjaye tsakanin waɗanda ke da CB. Dukansu sun bayyana suna amsawa ga CBT, amma babu ɗayansu da ke da amsa bayyananne ga magani; SSRIs ba sa samar da ci gaba akai-akai. Nazarin comorbidity ya nuna haɗuwa tsakanin cututtukan, kamar yadda adadin da ba su dace ba na masu caca da ke da CB da akasin haka.

A gefe guda kuma, bayanai sun nuna cewa akwai abubuwa da yawa da suka yi kama da juna game da matsalolin amfani da miyagun ƙwayoyi. PG da CB suna da alaƙa da sha'awar da ba ta saba da waɗanda masu shan miyagun ƙwayoyi suka ruwaito ba; an lura cewa PG yana haifar da alamun "janyewa" lokacin da mai caca ya daina shan ƙwayoyi, 119 kodayake ba a yi nazarin wannan a cikin CB ba. Bincike ya nuna cewa mutanen da ke da PG ko CB galibi suna da matsalolin amfani da miyagun ƙwayoyi masu alaƙa. Akasin haka, masu shan miyagun ƙwayoyi suna da yawan PG; babu wani bayani makamancin haka na CB. Nazarin iyali ya nuna cewa dangin waɗanda ke da PG ko CB suna da yawan cututtukan tabin hankali, musamman matsalolin shan barasa da miyagun ƙwayoyi. Bugu da ƙari, Slutske et al 94 sun ba da rahoton cewa, bisa ga bayanai biyu, PG yana da alaƙa da matsalolin amfani da miyagun ƙwayoyi da rashin lafiyar halayen zamantakewa. A ƙarshe, kamar yadda aka ambata a baya, nazarin neuroimaging, da duka neurotransmitters da binciken kwayoyin halitta akan PG sun nuna alaƙa da matsalolin amfani da miyagun ƙwayoyi. 116 Waɗannan bayanai suna tallafawa haɗa PG da wataƙila CB a cikin wani rukuni na "jarabawar ɗabi'a," wataƙila sun ƙunshi wani ɓangare na cututtukan amfani da miyagun ƙwayoyi, amma ba sa goyon bayan dangantaka da OCD.

karshe

Binciken ya nuna cewa CB da PG ba tabbas ba 'yan takara ne ba a cikin wani bidiyon OC. Binciken ba ya nufin yin hukunci akan muhimmancin ka'idar OC.

A gaskiya ma, mun ba da shawarar cewa akwai isassun shaidu don tallafawa wanzuwar ƙarancin OC spectrum wanda zai iya haɗawa da rashin lafiyar jiki, rashin lafiyar Tourette, trichotillomania, OCD mai zurfi, da kuma wataƙila matsalolin gyaran jiki. 8 , 120 Duk da cewa akwai kamanceceniya ta sama tsakanin CB/PG da OCD, wasu shaidu sun nuna cewa ba a haɗa su ba: rarraba jinsi, shekaru a farkon, da kuma hanya; nazarin cututtuka masu alaƙa; hotunan neuroimaging, neurotransmitter, da nazarin neuropsychological; da kuma amsawar magani. Mun yi imanin cewa PG da CB suna da alaƙa, duk da bambancin rarraba jinsi. Bugu da ƙari, mun yi imanin cewa idan babu sabbin shaidu masu gamsarwa, ya kamata PG ta kasance cikin rukunin ICD. A ƙarshe, mun yi imanin cewa CB cuta ce da aka iya ganewa kuma ta musamman wacce ya kamata a haɗa ta a cikin DSM-5, kuma ya kamata a haɗa ta da ICDs.

Zaɓuɓɓuka da aka zaɓa da acronyms

  • CB
  • sayen dan kasuwa
  • ICD
  • cuta-rikici
  • OC
  • m-m
  • OCD
  • rikice-damuwa
  • PG
  • wasan caca
  • SSRI
  • maɓallin sakin maganin serotonin mai warwarewa

nassoshi

1. Hollander E. Abubuwa masu rikitarwa masu rikitarwa. Washington DC: Cibiyar Nazarin Harkokin Kasuwancin Amirka ta 1993
2. Hollander E. Rashin hankali - hadaddun bambance-bambance: wani bayyani. Malamin Ann. 1993; 23: 355-358.
3. Hollander E, Wong CM. Gabatarwa: cuta masu rikitarwa masu rikitarwa. J Jara Samun zuciya. 1995; 56 (samar da 4): 3-6. [PubMed]
4. Koran LM. Rashin hankali-Cutar da Cutar da ke da Alaƙa a cikin Manya - Babbar Jagorar Kula da Lafiya. New York NY Cambridge UK 1999
5. Rasmussen SA. Abubuwa masu ban tsoro-masu hadari. J Jara Samun zuciya. 1994; 55: 89-91. [PubMed]
6. DJ DJ, Phillips KA. Abun da ke damuwa-damuwa mai tsanani: tsarin ginawa? Aust NZ J Kimiyya. 2006; 40: 114-120. [PMC free article] [PubMed]
7. Tavares H, Gentil V. Tsarin caca da mawuyacin halin da ake ciki da damuwa: zuwa ga wasu nau'i na rikice-rikice. Rev Brasil Psiquiatria. 2007; 29: 107-117. [PubMed]
8. Black DW. Abubuwan da ke damuwa da damuwa: gaskiya ko zato? A: Maj M, Sartorius N, Okasha A, Zohar J. Muni-Ciwo Mai Radi. New York, NY: Wiley 2000: 233-235.
9. Phillips KA. Abubuwan da ke damuwa da rawar jiki: alkawurra da matsala. A: Maj M, Sartorius N, Okasha A, Zohar J. Muni-Ciwo Mai Radi. New York, NY: Wiley 2000: 225-227.
10. Ƙungiyar Ƙwararrun Ƙasar Amirka. Bincike da kuma na ilimin kididdiga Manual da shafi tunanin mutum cuta. 4th ed, Rubutun Rubutun. Washington, DC: Ƙungiyar Ƙwararrun Ƙwararrun Amurka ta 2000
11. Robins E. Guze SB. Kafa asali na asali a cikin rashin lafiya na rashin lafiya: aikace-aikacensa zuwa schizophrenia. Am J Zuciyar. 1970; 126: 983-987. [PubMed]
12. Kungiyar Lafiya ta Duniya. Kayan Kayan Ƙasa na Duniya. 9th Revision. Geneva, Switzerland: Hukumar Lafiya ta Duniya 1977
13. Ƙungiyar Zohar J. Kungiyar Tattaunawa ta Ƙungiyar Cape Town ta Bayyana Mahimmanci-Ra'ayin da ke da muhimmanci ga ƙuntataccen cututtuka: Bayanin Tattaunawar Cape Town. CNS Spectr. 2007; 12: 2 (samar da 3): 5-13. [PubMed]
14. Lee S, Mysyk A. Magungunan cinikin sayarwa. Soc Sci Med. 2004; 58: 1709-1718. [PubMed]
15. Holden C. Tashin hankali: don haka suna wanzu? Science. 2001; 294: 980-982. [PubMed]
16. Kraftelin E. Psychiatrie. 8th ed. Leipzig, Jamus: Verlag Von Johann Ambrosius Barth 1915: 408-409.
17. Bleuler E. Littafin rubutu na ƙwararru. AA Brill, Trans. New York, NY: Macmillan 1930
18. Esquirol JED. Magungunan cututtuka. Paris, Faransa: Baillière 1838
19. O'Guinn TC, Faber RJ. Siyayya mai tilastawa: bincike mai ban mamaki. J Mai amfani da. 1989; 16: 147-157.
20. Elliott R. Amfani mai amfani: aiki da rarrabewa a cikin postmodernity. Yanayin Bayani na J. 1994;17:1 59–179.
21. Magee A. Harkokin sayen saya mai mahimmanci a matsayin mai hangen nesa game da halaye da tsinkaye. Bayanin Mashawar Bayanin. 1994; 21: 590-594.
22. McElroy S, Keck PE, Paparoma HG, et al. Samun mai karfi: Rahoton abubuwan 20. J Jara Samun zuciya. 1994; 55: 242-248. [PubMed]
23. McElroy S, Satlin A, Paparoma HG, et al. Jiyya na cin kasuwa tare da antidepressants: rahoto na uku lokuta. Ann Clin psychiatry. 1991; 3: 199-204.
24. Christenson GA, Faber RJ, de Zwaan M, et al. Samun mai karfi: siffofi na labaru da ƙwararrun ƙwararru. J Jara Samun zuciya. 1994; 55: 5-11. [PubMed]
25. Schlosser S, Black DW, Repertinger S, Freet D. Ƙaƙƙarwar sayen: demography, phenomenology, da kuma comorbidity a cikin 46 batutuwa. Gen Hosp Zuciyar. 1994; 16: 205-212. [PubMed]
26. Faber RJ, O'Guinn TC. Mai binciken asibiti don siyen tilas. J Mai amfani da. 1992: 459-469.
27. Edwards EA. Ƙaddamar da sabon sikelin don auna ma'aunin sayen siyarwa. Fin Shawara Taron. 1993; 4: 67-84.
28. Dittmar H. Fahimta da kuma bincikar sayen siyarwar. A cikin: Coombs R, ed. Jiki na Addictive. A littafin Jagora. New York, NY: Wiley 2004: 411-450.
29. Budden MC, Griffin TF. Binciken da kuma abubuwan da ke tattare da halayen mabukaci. Kasuwancin Psychol. 1996; 13: 739-740.
30. Hollander E, Allen A. Shin dan kasuwa ne na sayen gaske kuma yana da karfi? Am J Zuciyar. 2006; 163: 1670-1672. [PubMed]
31. Lejoyeux M, Andes J, Tassian V, Solomon J. Phenomenology da kuma tunanin kwakwalwa na sayen bashi. Am J Zuciyar. 1996; 152: 1524-1529. [PubMed]
32. Glatt MM, Cook CC. Harkokin Pathological bayar da su ne a matsayin nau'i na mutunci. Br J Shafi. 1987; 82: 1252-1258. [PubMed]
33. Goldman R. Samun dangi kamar buri. A cikin: Benson A, ed. Ina Kasuwanci, Saboda haka Ina Amfani: Bugun Siyarwa da Binciken Kai. New York, NY: Jason Aronson 2000: 245-267.
34. Black DW. Harkokin sayarwa mai mahimmanci: fassarar, kima, ilimin cututtuka da kuma kulawar asibiti. CN S Drugs. 2001; 15: 17-27. [PubMed]
35. McElroy SE, Paparoma HG, Keck PE, et al. Shin rikici ne na rikici da ke cikin alaka da cutar rashin lafiya? Compr Psychiatry. 1996; 37: 229-240. [PubMed]
36. Koran LM, Faber RJ, Aboujaoude E, et al. Ƙididdigar yawan sayarwa mai sayarwa a Amurka. Am J Zuciyar. 2006; 163: 1806-1812. [PubMed]
37. Grant JE, Levine L, Kim SW, Potenza MN. Rashin lafiya na rashin lafiyar a cikin likitoci na asibiti. Am J Zuciyar. 2005; 162: 2184-2188. [PubMed]
38. Black DW. Epidemiology da phenomenology na hadarin sayen cuta. A cikin: Grant J, Potenza M, eds. Oxford Handbook of Disorders Control Disorders
39. Black DW. Harkokin sayarwa mai karfi: nazari akan shaidar. CNS Spectrums. 2007; 12: 124-132. [PubMed]
40. Otter M, Black DW. Harkokin saye mai cin gashin kai a cikin mutane biyu masu ƙalubalantar tunani. Prim Care Companion J Jakar Masarauci. 2007; 9: 469-470. [PMC free article] [PubMed]
41. Dittmar H. Lokacin da kwarewa mafi kyau shine kawai danna danna: ƙungiyoyi tsakanin dabi'un jari-hujja, tunanin tunanin mutum da kuma abubuwan da suka shafi ainihi, da kuma sayen sayen kaya akan layi. J Soc Clin Psychol. 2007; 26: 334-361.
42. Nataraajan R, Goff BG. Samun karfi: zuwa ga reconceptualization. J Soc Behav Mutumin. 1991; 6: 307-328.
43. Aboujaoude E, Gamel N, Kur'ani LM. Aikin 1 shekara-shekara na marasa lafiya tare da ciwon cinikayyar cinikayya. J Jara Samun zuciya. 2003; 64: 946-950. [PubMed]
44. Lejoyeux M, Tassian V, Suleiman J, Ades J. Nazarin sayarwa mai karfi a cikin wadanda aka raunana. J Jara Samun zuciya. 1997; 58: 169-173. [PubMed]
45. Black DW, Repertinger S, Gaffney GR, Gabel J. Tarihin iyali da kuma labarun ƙwayar cuta a cikin mutanen da ke sayarwa mai sayarwa: binciken farko. Am J Zuciyar. 1998; 155: 960-963. [PubMed]
46. Black DW, Monahan P, Gabel J. Fluvoxamine a cikin kula da sayen dan kasuwa. J Jara Samun zuciya. 1997; 58: 159-163. [PubMed]
47. Black DW, Gabel J, Hansen J, et al. Wani kwatanci mai mahimmanci na madaidaicamine zuwa placebo a magance matsalar sayen dan kasuwa. Ann Clin psychiatry. 2000; 12: 205-211. [PubMed]
48. Ninan PT, McElroy SL, Kane CP, et al. Binciken da aka yi a placebo na fluvoxamine a kula da marasa lafiya tare da sayen dan kasuwa. J Clin Psychopharmacol. 2000; 20: 362-366. [PubMed]
49. Koran LM, Chuang HW, Bullock KD. Smith SC Citalopram don matsalar cin kasuwa mai tsanani: binciken da aka lakaba da lakabi tare da rufewar makafi biyu. J Jara Samun zuciya. 2003; 64: 793-798. [PubMed]
50. Koran LM, Aboujaoude EN, Solvason B, Gamel N, Smith EH. Escitalopram don cuta mai sayarwa mai tsanani: binciken binciken tsagewar makafi biyu. J Clin Psychopharmacol. 2007; 27: 225-227Letter. [PubMed]
51. Grant JE. Hanyoyi uku na sayen da aka saya da naltrexone. Int J Zuciya Clin Prac. 2003; 7: 223-225.
52. Neuner M, Raab G, Reisch L. Sayarwa mai karfi a cikin matasan al'ummomin da ake amfani da su: bincike mai zurfi. J Econ Psychol. 2005; 26: 509-522.
53. Krueger DW. A kan cin kasuwa da kuma bayarwa: wani bincike na psychodynamic. Am J Sannan. 1988; 42: 574-584. [PubMed]
54. Lawrence L. Harkokin kwantar da hankali na mata mai tayar da hankali. Am J Psychoanal. 1990; 50: 67-70. [PubMed]
55. Winestine, MC Kasuwanci mai mahimmanci a matsayin abin ƙyama na lalata yara. Psychoanal Q. 1985; 54: 70-72. [PubMed]
56. Villarino R, Otero-Lopez JL, Casto R. Adicion a la compra: Analysis, kimantawa y tratamiento [Buying jaraba: Analysis, kimantawa, da kuma magani] Madrid, Spain: Ediciones Piramide 2001
57. Mitchell JE, Burgard M, Faber R, Crosby RD. Hanyar halayyar halayyar ganewa don ƙwarewar sayarwa. Behav Res Ther. 2006; 44: 1859-1865. [PubMed]
58. Benson A. Tsayawa versarewa - Babban Shirye-shirye don Taimaka Gusar Daidaitawa. New York, NY: Afrilu Benson 2006
59. Cibiyar Nazarin Harkokin Kasuwancin {asa a Jami'ar Chicago (NORC): Ra'ayin Bincike da Harkokin Kasuwanci, Rahoto ga Hukumar Nazarin Harkokin Kasuwanci na kasa. Afrilu 1, 1999
60. Petry NM, Kiluk BD. Ƙaddanci da kuma yin ƙoƙarin kashe kansa a cikin masu caca. J Nerv Ment Dis. 2002; 190: 462-469. [PMC free article] [PubMed]
61. Shaw M, Forbush K, Schlinder J, et al. Sakamakon labarun caca game da iyali, da aure, da yara. CNS Spectr. 2007; 12: 615-622. [PubMed]
62. Ƙungiyar Ƙwararrun Ƙasar Amirka. Bincike da kuma na ilimin kididdiga Manual da shafi tunanin mutum cuta. 3rd ed. Washington, DC: Ƙungiyar Ƙwararrun Ƙwararrun Amurka ta 1980
63. Shaffer HJ, Hall MN. Bayyana ƙaddamar da matsalar caca game da matasa: kira mai yawa da kuma jagorantar zuwa daidaitattun ƙididdigar caca. J Gambl Ingarma. 1996; 12: 193-214.
64. Blaszczynski A. Magungunan caca da mawuyacin hali. Rahoton Psychol. 1999; 84: 107-113. [PubMed]
65. Durdle H, Gorey KM, Stewart SH. Misali-bincike da ke nazarin dangantakar da ke tsakanin caca-bambance-bambance, rikice-rikice-rikice-rikice-rikice, da dabi'u masu ban tsoro. Rahoton Psychol. 2008; 103: 485-498. [PubMed]
66. Shaffer HJ, LaPlante DA, LaBrie RA, et al. Zuwa wata ƙwayar cuta ta ciwo: ƙwararriyar maganganu, zane-zane na kowa. Har Rev Lafiya. 2004; 12: 367-374. [PubMed]
67. Wray I, Dickerson MG. Cessation of high mita caca da janye bayyanar cututtuka. Br J Jingina. 1981; 76: 401-405. [PubMed]
68. Shaffer HJ, Hall MN. Ana sabuntawa da sake tsaftace ƙididdigar ladabi na halayen caca da ke cikin Amurka da Kanada. Za a iya J Pub Health. 2001; 92: 168-172. [PubMed]
69. Cunningham-Williams R, Gidan LB. Wannan annobar cutar ta caca. Sem Clin NeuroPsychiatry. 2001;6:1 55–166.
70. Volberg RA. Nazarin bincike da yawa game da matsalar caca a Amurka. J Gambling Stud. 1996; 12: 111-128.
71. Jacques C, Ladouceur R, Gerland F. Dama akan kasancewa a kan caca: bincike mai tsawo. Can J psychiatry. 2000; 45: 810-815. [PubMed]
72. Grant J, Kim SW. Tarihin mutum da kuma siffofi na asibiti na 131 tsofaffin 'yan wasa. J Jara Samun zuciya. 2001; 62: 957-962. [PubMed]
73. Tavares H, Zilberman ML, Gidan FJ, et al. Bambancin bambancin jinsi a ci gaba da caca. J Gambl Ingarma. 2001; 17: 151-159. [PubMed]
74. Potenza MN, Kosten TR, Rounsaville BJ. Tambaya. Jama. 2001; 286: 141-144. [PubMed]
75. Templer Dl, Kaiser G, Siscoe K. Kasuwanci na caca-caca a cikin kurkuku. Compr Psychiatry. 1993; 34: 347-351. [PubMed]
76. Blaszczynski A, McConaghy N. Mai damu da kuma / ko bakin ciki a cikin cin hanci da rashawa. Int J Addictions. 1989; 24: 337-350. [PubMed]
77. Blaszczynski A, Nower L. Tsarin hanyoyi na matsala da kuma caca. Addiction. 2002; 97: 487-499. [PubMed]
78. Crockford ND, el-Guebaly N. Magungunan cututtuka a cikin wasan kwaikwayo na ban dariya: wani bita mai muhimmanci. Am J Zuciyar. 1998; 43: 43-50. [PubMed]
79. Black DW, Shaw M. Ƙwararrun mashawarci da kuma caca. tabin hankali Times. 2008; 25: 14-18.
80. Black DW, Moyer T. Dabbobi na asibiti da halayyar ƙwararrakin hankali a cikin darussan 30 da ke ba da rahotanni game da halin caca. Ma'aikaciyar Psychiatr. 1998; 49: 1434-1439. [PubMed]
81. Goldstein RB, Ma'aikata SI, McCusker J, et al. Rashin baƙin ciki a cikin halin hali na zamantakewar al'umma tsakanin masu cin zarafin miyagun ƙwayoyi a cikin maganin zama. J Pers Disord. 1996; 10: 321-334.
82. Cikin Cartwright C, DeCaria C, Hollander E. Tambayoyi na asali: nazarin asibiti. J Prac Psychiatr Behav Lafiya. 1998; 5: 277-286.
83. DeCaria C, Hollander E, Grossman R, et al. Bincike, neurobiology, da kuma kula da caca. J Jara Samun zuciya. 1996; 57 (samar da 8): 80-84. [PubMed]
84. Custer R. Lokacin da Luck ya fita. New York, NY: Facts a kan 1985 File: 232.
85. Rosenthal R. Mahimmanci caca. Malamin Ann. 1992; 22: 72-78.
86. LaPlante DA, Nelson SE, LaBrie RA, Shaffer HJ. Dama da kuma ci gaba da caca baƙi: darussa daga nazarin lokaci. Can J psychiatry. 2008; 53: 52-60. [PubMed]
87. Abbott MW, Williams MM, Volberg RA. Binciken da ake yi game da matsala da kuma wadanda ba su da matsala game da matsalolin da suke zaune a cikin al'umma. Maganin amfani da amfani. 2004; 39: 855-884. [PubMed]
88. DeFuentes-Merillas L, Koita MW, Schippers GM, van den Brink W. Tsakanin kwakwalwa na lalata kayan wasan kwaikwayon da ke tsakanin tsofaffin yara masu sayarwa shekaru biyu bayan haka. Addiction. 2004; 99: 117-127. [PubMed]
89. Shaffer HJ, Hall MN. Tarihin halitta na caca da shan matsaloli a cikin ma'aikatan casino. J Soc Psychol. 2002; 142: 405-424. [PubMed]
90. Slutske W, Jackson KM, Sher KJ. Tarihin halitta na matsalar caca daga 18 zuwa 29. J Abnorn Psychol. 2003; 112: 263-274. [PubMed]
91. Winters KC, Stinchfield RD, Botzet A, Anderson N. A binciken da ake yi na matasa game da wasan kwaikwayo. Psychol Addict Behav. 2002; 16: 3-9. [PubMed]
92. Black DW, Moyer T, Schlosser S. Darajar rayuwa da tarihin iyali a cikin caca. J Nerv Ment Dis. 2003; 191: 124-126. [PubMed]
93. Black DW, Monahan PO, Temkit M, Shaw M. A nazarin iyali na caca. Mashahuriyar Sanda. 2006; 141: 295-303. [PubMed]
94. Slutske W, Yayi S, Gaskiya WR, et al. Hanyoyin kwastan na yau da kullum don yin caca da kuma barazanar da ake yi a maza. Arch Gen dabbai. 2000; 57: 666-673. [PubMed]
95. Potenza MN, Steinberg MA, Skudlarski P, et al. Tambaya na wasan kwaikwayon da kuma caca-bambance-bambance: wani aikin nazarin hotuna mai kwakwalwa. Arch Gen dabbai. 2003; 60: 828-836. [PubMed]
96. Cunningham JA. Ƙara amfani da magani a tsakanin matsalolin matsaloli. Ma'aikaciyar Psychiatr. 2005; 56: 1024-1025. [PubMed]
97. Brown RIF. Amfanin Gamblers M. A Edington WR (ed) Nazarin Tambaya: Shirye-shiryen Taro na Kasa na Kasa na Kasa na Kasuwanci na Kasuwanci da Kwarewa. Reno, NV: Ofishin Kasuwancin da Tattalin Arziki, Jami'ar Nevada, Reno 1985
98. Russo AM, Taber Jl, McCormick RA, Ramirez LF. Binciken binciken da aka yi game da shirin marasa lafiya na masu caca. Hosp Comm Psychiatry. 1984; 35: 823-827. [PubMed]
99. Taber Jl, McCormick RA, Russo AM, et al. Bayanan masu cin gajiyar magunguna bayan magani. Am J Zuciyar. 1987; 144: 757-761. [PubMed]
100. Petry NM. Tambaya na Pathological: Ilimin Kimiyya, da kuma Jiyya. Washington DC: Cibiyar Nazarin Ƙasar Amirka ta 2005
101. Ladouceur R, Sylvain C, Gosselin P. Shirin bacewar hanya: nazarin nazari na tsawon lokaci. J Gambl Ingarma. 2007; 23: 85-94. [PubMed]
102. Kim SW, Grant JE, Adson DE, Shin YC. Naltrexone mai makafi guda biyu da nazarin nazarin wuribo don magance caca. Biol Babban ilimin zuciya. 2001; 49: 914-921. [PubMed]
103. Grant JE, Potenza MN, Hollander E, et al. Binciken da ake yi na mahaukaciyar magungunan ƙwayoyin cuta a cikin magungunan caca. Am J Zuciyar. 2006; 163: 303-312. [PubMed]
104. Black DW, Arndt S, Coryell WH, et al. Bupropion a cikin maganin caca-caca: wani bazuwar, placebo-sarrafawa, bincike mai sauƙi-bincike. J Clin Psychopharmacol. 2007; 27: 143-150. [PubMed]
105. Grant JE, Potenza MN, Blanco C, et al. Maganin Paroxetine game da caca-caca: wani gwaji mai sarrafawa da yawa wanda ba a yi ba. Int Clin Psychopharmacol. 2003; 18: 243-249. [PubMed]
106. Pallanti S, Rossi NB, Sood E, Hollander E. Nefazodone jiyya game da wasan caca: abin da ake kira bude-lakabi yajin aiki. J Jara Samun zuciya. 2002; 63: 1034-1039. [PubMed]
107. Zimmerman M, Breen RB, Posternak MA. Nazarin lakabi na lakabi na citalopram don magance caca. J Jara Samun zuciya. 2002; 63: 44-48. [PubMed]
108. Black DW, Shaw M, Allen J. Tsarin da aka ba da kyautar carbamazepine a cikin maganin caca-bambance-bambance: bincike mai lakabi. Prog Neurpsychopharmacol Biol. 2008 mai ƙwararrun zuciya; 32: 1191-1194. [PubMed]
109. Black DW, Shaw M, Forbush KT, Allen J. Wani binciken layi na escitalopram a maganin caca. Clin Neuropharmacol. 2007; 30: 206-212. [PubMed]
110. du Toit PL, van Kradenburg J, Niehaus D, Stein DJ. Daidai da marasa lafiya da marasa lafiya masu fama da marasa lafiya da marasa lafiya tare da ba tare da maganganu ba tare da maganin cuta ta hanyar yin amfani da tambayoyin magunguna. Compr Psychiatry. 2001; 42: 291-300. [PubMed]
111. Hantouche EG, Lancrenon S, Bouhassira M, et al. Maimaita kimantawa na rashin takaici a cikin wani rukuni na marasa lafiya na 155 tare da cuta mai rikitarwa: 12 watanni mai yiwuwa biyowa. Encephale. 1997; 23: 83-90. [PubMed]
112. Frost RO, Meagher BM, Riskind JH. Abubuwa masu ban sha'awa-masu tasowa a cikin irin caca da kuma masu caca. J Gambling Stud. 2001; 17: 519. [PubMed]
113. Kusa KT, Shaw MC, Graeber MA, et al. Ayyukan neuropsychological da halaye a kan caca. CNS Spectrums. 2008; 13: 306-315. [PubMed]
114. Black DW, Goldstein RB, Noyes R, Blum N. Harkokin haɗari da rashin tausananci-damuwa (OCD): Rashin dangantaka tsakanin OCD, ci abinci, da caca. Compr Psychiatry. 1994; 35: 145-148. [PubMed]
115. Sauran Jak, Samuels JF, Riddle MA, et al. Halin dangantaka mai rikitarwa-matsananciyar cuta ga yiwuwar hadarin rashin bita: sakamakon daga nazarin iyali. Biol Babban ilimin zuciya. 2000; 48: 287-293. [PubMed]
116. Goudriaan AE, Ossterlaan J, deBeurs E, van den Brink W. Tsarin caca: Nazari mai zurfi game da binciken binciken biobehavioral. Neurosci Biobehav Rev. 2004; 28: 123-141. [PubMed]
117. Cavadini P, Riboldi G, Keller R, et al. Harshen lobe na dasfunni a cikin masu caca marasa lafiya. Biol Babban ilimin zuciya. 2002; 51: 334-341. [PubMed]
118. Menzies L, Chamberlain SR, Laird AR, et al. Haɗakar da shaida daga neuroimaging da neuropsychological karatu game da cuta m-rauni: da orbitofronta-striatal model sake dubawa. Neurosci Biobehav Rev. 2008: 525-549. [PMC free article] [PubMed]
119. Cunningham-Williams RM, Gattis MN, Dore PM, et al. Zuwa ga DSM-V: la'akari da wasu janye-kamar bayyanar cututtuka na rashin lafiyar caca. Jirgin Int J Hanyar Magunguna. 2009; 18: 13-22. [PubMed]
120. Black DW, Gaffney GR. Cutar damuwa mai tsanani a cikin yara da matasa: ƙarin sakamako daga binciken binciken "babban haɗari". CNS Spectrums. 2008; 9 (samar da 14): 54-61. [PubMed]